Translational Research in Malignancy Members
The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
VanderWeele, David
Associate Professor
Bio
Cancer heterogeneity and evolution with a goal of identifying and targeting drivers of cancer progression and therapy resistance. His research has described intrafocal heterogeneity in prostate cancer... [more]
Vormittag-Nocito, Erica
Assistant Professor
Bio
My research interests include novel molecular techniques that can be applied to cancer biology testing, understanding the molecular biology of various tumors and investigating methodologies of molecul... [more]